Active Filters

S1011: Less is more in bladder cancer surgery
May 30, 2023
Extended lymph node removal does not benefit patients with clinically localized muscle-invasive bladder cancer
2023 ASCO Annual Meeting
May 30, 2023
SWOG researchers have also contributed to an additional 11 abstracts on studies led by other groups.
Dr. Primo Lara and Dr. Dawn Hershman
May 16, 2023
Drs. Dawn Hershman and Primo Lara elected group co-chairs-elect of SWOG Cancer Research Network
S1609 DART gynecologic cancer results at AACR 2023
Apr 17, 2023
SWOG researchers report results in rare gynecologic cancers from S1609 DART immunotherapy trial
S1512 Cohort B results at AACR 2023
Apr 16, 2023
SWOG S1512 trial sees high response rate to pembrolizumab in patients with unresectable desmoplastic melanoma
S2302 Pragmatica-Lung trial
Apr 12, 2023
SWOG S2302 Pragmatica-Lung study opens to enrollment, a model for easier, more representative clinical trials
S1416 results in Lancet Oncology
Jan 30, 2023
S1416 trial results show PARP inhibitor benefit in "BRCA-like" triple-negative breast cancer
S1815 results at ASCO GI
Jan 20, 2023
Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some
journal article title page
Dec 19, 2022
Four decades of NCI-funded NCTN trials gave U.S. patients 14.2 million life-years for a federal investment of $326 per life-year gained